ERBB2 and breast cancer: To investigate the specific mechanism of miR-33b in HER2+ BC progression, miR-33b was ectopically overexpressed in different HER2+ cell lines, where it was shown that the upregulation of this miRNA inhibits cancer cell invasion and migration.